Pil - search results | myHealthbox

European Union - English - EMA (European Medicines Agency)

zonegran

amdipharm limited - zonisamide - epilepsies, partial - antiepileptics, - zonegran is indicated as:monotherapy in the treatment of partial seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy;adjunctive therapy in the treatment of partial seizures, with or without secondary generalisation, in adults, adolescents, and children aged six years and above.

European Union - English - EMA (European Medicines Agency)

ztalmy

marinus pharmaceuticals emerald limited - ganaxolone - epileptic syndromes; spasms, infantile - other antiepileptics - ztalmy is indicated for the adjunctive treatment of epileptic seizures associated with cyclin-dependent kinase-like 5 (cdkl5) deficiency disorder (cdd) in patients 2 to 17 years of age. ztalmy may be continued in patients 18 years of age and older.

European Union - English - EMA (European Medicines Agency)

fycompa

eisai gmbh - perampanel - epilepsies, partial - antiepileptics, , other antiepileptics - fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in adult and adolescent patients from 12 years of age with epilepsy.fycompa is indicated for the adjunctive treatment of primary generalised tonic-clonic seizures in adult and adolescent patients from 12 years of age with idiopathic generalised epilepsy.

European Union - English - EMA (European Medicines Agency)

levetiracetam teva

teva b.v. - levetiracetam - epilepsy - nervous system - levetiracetam teva is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.levetiracetam teva is indicated as adjunctive therapy:in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents, children and infants from 1 month of age with epilepsy;in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy;in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pil pak fong chong cao (pil besar 12g)

seng lian trading - alisma orientalis; cordyceps sinensis; mel; panax ginseng; ziziphus spinosus fructus; rhizoma ligustici chuanxiong; rehmannia glutinosa rhizoma; radix salviae miltiorrhizae extract; radix angelicae sinensis extract; notopterygium incisium n.frobesii; nelumbo nucifera semen; linderae strychnifolia kuntze; glycyrrhiza uralensis radix; fructus cornus officinalis; cyperus rotundus rhizome; cibotium barometz rhizoma; astragalus hoangtchy radix/yellow vitch -